Diann Blanset

2.2k total citations · 1 hit paper
30 papers, 1.6k citations indexed

About

Diann Blanset is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Diann Blanset has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Diann Blanset's work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immunotherapy and Immune Responses (6 papers). Diann Blanset is often cited by papers focused on CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immunotherapy and Immune Responses (6 papers). Diann Blanset collaborates with scholars based in United States, Austria and Germany. Diann Blanset's co-authors include Alan J. Korman, Minhua Han, Kent Thudium, Changyu Wang, Mark Selby, M. S. Srinivasan, Tibor Keler, Michelle Kuhne, Haichun Huang and Sujata Singh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature reviews. Immunology.

In The Last Decade

Diann Blanset

30 papers receiving 1.6k citations

Hit Papers

In Vitro Characterization of the Anti-PD-1 Antibody Nivol... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
    2014 472 citations Changyu Wang, Kent Thudium et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diann Blanset United States 14 950 719 379 330 199 30 1.6k
Peter R. Rhode United States 22 853 0.9× 1.1k 1.5× 491 1.3× 117 0.4× 67 0.3× 57 2.0k
Lise Mette Rahbek Gjerdrum Denmark 23 432 0.5× 485 0.7× 705 1.9× 79 0.2× 369 1.9× 68 1.7k
V von Fliedner Switzerland 22 881 0.9× 1.2k 1.6× 411 1.1× 381 1.2× 88 0.4× 54 2.1k
Ann‐Christine Syvänen Sweden 15 329 0.3× 882 1.2× 404 1.1× 142 0.4× 110 0.6× 22 1.6k
Sunil Reddy United States 24 1.1k 1.1× 746 1.0× 860 2.3× 190 0.6× 704 3.5× 72 2.7k
Tobias A.W. Holderried Germany 19 549 0.6× 1.2k 1.6× 629 1.7× 70 0.2× 195 1.0× 58 1.9k
Susan C. Weil United States 21 503 0.5× 322 0.4× 464 1.2× 144 0.4× 150 0.8× 53 1.4k
Maria Monne Italy 17 541 0.6× 249 0.3× 628 1.7× 39 0.1× 135 0.7× 38 1.5k

Countries citing papers authored by Diann Blanset

Since Specialization
Citations

This map shows the geographic impact of Diann Blanset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diann Blanset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diann Blanset more than expected).

Fields of papers citing papers by Diann Blanset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diann Blanset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diann Blanset. The network helps show where Diann Blanset may publish in the future.

Co-authorship network of co-authors of Diann Blanset

This figure shows the co-authorship network connecting the top 25 collaborators of Diann Blanset. A scholar is included among the top collaborators of Diann Blanset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diann Blanset. Diann Blanset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moffit, Jeffrey S., et al.. (2025). Nonclinical strategies and considerations to enable the redosing of gene therapies. Molecular Therapy — Methods & Clinical Development. 33(3). 101520–101520. 1 indexed citations
2.
Griesenbach, Uta, Gerry McLachlan, Cédric Cheminay, et al.. (2023). WS17.06 F/HN pseudotyped lentiviral vector-mediated transduction of non-human primates. Journal of Cystic Fibrosis. 22. S33–S33. 1 indexed citations
3.
Moffit, Jeffrey S., Diann Blanset, Jessica Lynch, et al.. (2022). Regulatory Consideration for the Nonclinical Safety Assessment of Gene Therapies. Human Gene Therapy. 33(21-22). 1126–1141. 11 indexed citations
4.
Grimaldi, Christine, Andrea Kießling, Benno Rattel, et al.. (2022). Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics. Drug Discovery Today. 28(2). 103440–103440. 3 indexed citations
5.
MacLachlan, Timothy K., Joy Cavagnaro, Laura Andrews, et al.. (2021). Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules – A survey of industry 2008–2019. Regulatory Toxicology and Pharmacology. 121. 104872–104872. 5 indexed citations
6.
Bogdanffy, Matthew S., Raja S. Mangipudy, Frank D. Sistare, et al.. (2020). Tg.rasH2 Mouse Model for Assessing Carcinogenic Potential of Pharmaceuticals: Industry Survey of Current Practices. International Journal of Toxicology. 39(3). 198–206. 10 indexed citations
7.
Andrews, Paul A., Diann Blanset, Martin Green, et al.. (2019). Analysis of exposure margins in developmental toxicity studies for detection of human teratogens. Regulatory Toxicology and Pharmacology. 105. 62–68. 11 indexed citations
8.
Rocca, Meredith S., LaRonda L. Morford, Diann Blanset, et al.. (2018). Applying a weight of evidence approach to the evaluation of developmental toxicity of biopharmaceuticals. Regulatory Toxicology and Pharmacology. 98. 69–79. 13 indexed citations
9.
Selby, Mark, John Engelhardt, Robert J. Johnston, et al.. (2016). Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology. PLoS ONE. 11(9). e0161779–e0161779. 175 indexed citations
10.
Hipp, Susanne, YT Tai, Diann Blanset, et al.. (2016). A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo. Leukemia. 31(8). 1743–1751. 194 indexed citations
11.
12.
Wang, Changyu, Kent Thudium, Minhua Han, et al.. (2014). In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates. Cancer Immunology Research. 2(9). 846–856. 472 indexed citations breakdown →
13.
Roberts, Stanley, Paul A. Andrews, Diann Blanset, et al.. (2013). Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology. Regulatory Toxicology and Pharmacology. 67(3). 382–391. 25 indexed citations
14.
Horvath, Christopher, Laura Andrews, Andreas Baumann, et al.. (2012). Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial. Nature reviews. Immunology. 12(10). 740–740. 27 indexed citations
15.
Morford, LaRonda L., Christopher Bowman, Diann Blanset, et al.. (2011). Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(4). n/a–n/a. 16 indexed citations
16.
Leach, Michael W., Wendy Halpern, Carol W. Johnson, et al.. (2010). Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals. Toxicologic Pathology. 38(7). 1138–1166. 40 indexed citations
17.
Kuhne, Michelle, Chin Pan, Karla A. Henning, et al.. (2009). Abstract #LB-150: A fully human anti-CXCR4 antibody induces apoptosis in vitro and shows anti tumor activity in vivo.. Cancer Research. 69. 1 indexed citations
18.
Cardarelli, Pina M., Haichun Huang, Chin Pan, et al.. (2009). A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies. Cancer Immunology Immunotherapy. 59(2). 257–265. 39 indexed citations
19.
Ansell, Stephen M., Steven M. Horwitz, Andreas Engert, et al.. (2008). Increased doses of an anti-CD30 antibody, MDX-060, results in prolonged progression free survival in subjects with CD30 positive lymphoma.. Cancer Research. 68. 5525–5525. 2 indexed citations
20.
Hryniewicz, Anna, Adriano Boasso, Yvette Edghill‐Smith, et al.. (2006). CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood. 108(12). 3834–3842. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter R. Rhode Breakdown of academic impact, for papers by Lise Mette Rahbek Gjerdrum Breakdown of academic impact, for papers by V von Fliedner Breakdown of academic impact, for papers by Ann‐Christine Syvänen Breakdown of academic impact, for papers by Sunil Reddy Breakdown of academic impact, for papers by Tobias A.W. Holderried Breakdown of academic impact, for papers by Susan C. Weil Breakdown of academic impact, for papers by Maria Monne
Rankless by CCL
2026